Heterogeneity of miR-10b expression in circulating tumor cells

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Gasch, Christin ^a   Plummer, Prue N ^a   Jovanovic, Lidija ^b   McInnes, Linda M ^c   Wescott, David ^a   Saunders, Christobel M ^c   Schneeweiss, Andreas ^d,e   Wallwiener, Markus ^d,e   Nelson, Colleen ^b   Spring, Kevin J ^f,g   Riethdorf, Sabine ^h   Thompson, Erik W ^b,i   Pantel, Klaus ^h   Mellick, Albert S ^a,j  

^a DEAKIN UNIVERSITY   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f LIVERPOOL HOSPITAL   (Australia)

^g UNIVERSITY OF WESTERN SYDNEY   (Australia)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j UNIVERSITY OF NEW SOUTH WALES   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN10 MICRORNA, HUMAN; TUMOR MARKER;

BLOOD; BREAST TUMOR; COLORECTAL TUMOR; FEMALE; GENETICS; HCT 116 CELL LINE; HUMAN; IN SITU HYBRIDIZATION; MCF-7 CELL LINE; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR EMBOLISM;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; HCT116 CELLS; HUMANS; IN SITU HYBRIDIZATION; MCF-7 CELLS; MICRORNAS; NEOPLASTIC CELLS, CIRCULATING;

EID: 84946548364     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15980     Document Type: Article

References (38)

1. Allard, W. J. et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10, 6897-904 (2004).
2. Wallwiener et al. Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients. BMC Cancer 14, 512 (2014).
3. Scher et al. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol. 10, 233-9 (2009).
4. Gasch, C. et al. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin. Chem. 59, 252-60 (2013).
5. Gorges, T. M. & Pantel, K. Circulating tumor cells as therapy-related biomarkers in cancer patients. Cancer Immunol. Immunother. 62, 931-9 (2013).
6. Fernandez, S. V. et al. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients. Breast Cancer Res. 16, 445 (2014).
7. Bacelli et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat. Biotechnol. 31, 539-44 (2013)
8. Alix-Panabieres, C. & Pantel K. Challenges in circulating tumour cell research. Nat. Rev. Cancer 14, 623-31 (2014).
9. Sieuwerts, A. M. et al. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin. Cancer Res. 17, 3600-18 (2011).
10. Yang, Y., Swennenhuis, J. F., Rho, H. S., Le Gac, S. & Terstappen, L. W. Parallel single cancer cell whole genome amplification using button-valve assisted mixing in nanoliter chambers. PLoS One 9, e107958 (2014).
11. Heitzer, E. et al. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res. 73, 2965-75 (2013).
12. Farazi, T. A., Spitzer, J. I., Morozov, P. & Tuschl, T. MiRNAs in human cancer. J. Pathol. 223, 102-15 (2011).
13. Slack, F. J. & Weidhaas, J. B. MicroRNA in cancer prognosis. New Engl. J. Med. 359, 2720-2 (2008).
14. Trang, P., Weidhaas, J. B. & Slack, F. J. MicroRNAs as potential cancer therapeutics. Oncogene 27, S52-7 (2008).
15. Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-8 (2007).
16. Ma, L. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nature Biotech. 28, 341-347 (2010).
17. Prueitt, R. L. et al. Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 68, 1152-64 (2008).
18. Roth, C., Rack, B., Muller, V., Janni, W., Pantel, K. & Schwarzenbach, H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 12, R90 (2010).
19. Sasayama, T., Nishihara, M., Kondoh, T., Hosoda, K. & Kohmura, E. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int. J. Cancer 125, 1407-13 (2009).
20. Nakata, K., et al. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery 150, 916-22 (2011).
21. Roth, C., Kasimir-Bauer, S., Pantel, K. & Schwarzenbach, H. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer. Mol. Oncol. 5, 281-91 (2011).
22. Nishida, N., et al. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. Ann. Surg. Oncol. 19, 3065-71 (2012).
23. Gee, H. E., et al. MicroRNA-10b and breast cancer metastasis. Nature 455, E8-9 (2008).
24. Pena, J. T., et al. MiRNA in situ hybridization in formaldehyde and EDC-fixed tissues. Nat. Methods 6, 139-41 (2009).
25. Thompson, R. C., Deo, M. & Turner, D. L. Analysis of microRNA expression by in situ hybridization with RNA oligonucleotide probes. Methods 43, 153-61 (2007).
26. Jorgensen, S., Baker, A., Moller, S. & Nielsen, B. S. Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 52, 375-81 (2012).
27. Park, S. M., Gaur, A. B., Lengyel, E. & Peter, M. E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894-907 (2008).
28. Zimmerman, S. G., Peters, N. C., Altaras, A. E. & Berg, C. A. Optimized RNA ISH, RNA FISH and protein-RNA double labeling (IF/FISH) in Drosophila ovaries. Nat. Protoc. 8, 2158-79 (2013).
29. Speel, E. J., Herbergs, J., Ramaekers, F. C. & Hopman, A. H. Combined immunocytochemistry and fluorescence in situ hybridization for simultaneous tricolor detection of cell cycle, genomic, and phenotypic parameters of tumor cells. J. Histochem. Cytochem. 42, 961-6 (1994).
30. Van Raamsdonk, C. D. & Tilghman, S. M. Optimizing the detection of nascent transcripts by RNA fluorescence in situ hybridization. Nucleic Acids Res. 29, E42-2 (2001).
31. Kubota, K., Ohashi, A., Imachi, H. & Harada, H. Improved in situ hybridization efficiency with locked-nucleic-acid-incorporated DNA probes. Appl. Environ. Microbiol. 72, 5311-7 (2006).
32. Riethdorf, S. et al. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin. Cancer Res. 16, 2634-45 (2010).
33. Attard, G. et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castrationresistant prostate cancer. Cancer Res. 69, 2912-8 (2009).
34. Ramskold, D. et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat. Biotechnol. 30, 777-82 (2012).
35. Hur, K. et al. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. J. Natl. Cancer Inst. 107 (2015).
36. Fendler, A. et al. MiRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression. Int. J. Oncol. 39, 1183-92 (2011).
37. Riethdorf, S. et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin. Cancer Res. 13, 920-8 (2007).
38. Swennenhuis, J. F., Tibbe, A. G., Levink, R., Sipkema, R. C. & Terstappen, L. W. Characterization of circulating tumor cells by fluorescence in situ hybridization. Cytometry 75, 520-7 (2009).